The clinic of Oncology at the University Hospital in Linköping buys VibroSense Meter® II and starts a multicentre study
The Department of Oncology at Linköping University Hospital has started a multicentre study to identify biomarkers for advanced pancreatic cancer that are treated with chemotherapy. The study will be made in collaboration with VibroSense Dynamics which assists with advice and data extraction as well as analysis of data. The studies aim to investigate how nerves in the feet and hands are affected by chemotherapy.The study will be conducted at three clinics in the Swedish hospitals in Linköping, Jönköping and Kalmar of initially 75 patients during two years. The purpose of the study is to